Geneos Wealth Management’s Dynavax Technologies DVAX Stock Holding History

Geneos Wealth Management’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-295	Closed	-$3K	–	2166
2022 Q2	$3K	Sell	295 -200	-40%	-$2.12K	﹤0.01%	2303
2022 Q1	$5K	Hold	495	–	–	﹤0.01%	2326
2021 Q4	$6K	Hold	495	–	–	﹤0.01%	2343
2021 Q3	$8K	Hold	495	–	–	﹤0.01%	2296
2021 Q2	$4K	Sell	495 -40	-7%	-$364	﹤0.01%	2502
2021 Q1	$5K	Hold	535	–	–	﹤0.01%	2643
2020 Q4	$5K	Buy	535 +140	+35%	+$634	﹤0.01%	2463
2020 Q3	$1K	Buy	395 +100	+34%	+$714	﹤0.01%	2508
2020 Q2	$2K	Hold	295	–	–	﹤0.01%	2344
2020 Q1	$1K	Hold	295	–	–	﹤0.01%	2358
2019 Q4	$1K	Hold	295	–	–	﹤0.01%	2454
2019 Q3	$1K	Hold	295	–	–	﹤0.01%	2388
2019 Q2	$1K	Hold	295	–	–	﹤0.01%	2389
2019 Q1	$2K	Hold	295	–	–	﹤0.01%	2229
2018 Q4	$2K	Hold	295	–	–	﹤0.01%	2188
2018 Q3	$3K	Hold	295	–	–	﹤0.01%	2172
2018 Q2	$4K	Hold	295	–	–	﹤0.01%	1961
2018 Q1	$5K	Hold	295	–	–	﹤0.01%	1842
2017 Q4	$5K	Hold	295	–	–	﹤0.01%	1805
2017 Q3	$6K	Buy	295 +100	+51%	+$1.58K	﹤0.01%	1708
2017 Q2	$1K	Hold	195	–	–	﹤0.01%	1986
2017 Q1	$1K	Buy	+195	New	+$938	﹤0.01%	1971
2016 Q4	–	Sell	-195	Closed	-$2K	–	2060
2016 Q3	$2K	Hold	195	–	–	﹤0.01%	1761
2016 Q2	$2K	Hold	195	–	–	﹤0.01%	1669
2016 Q1	$3K	Buy	+195	New	+$3.94K	﹤0.01%	1598

Other funds holding DVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Geneos Wealth Management's DVAX Position: Q3 2022 in Review

Geneos Wealth Management sold out of Dynavax Technologies (DVAX) in Q3 2022, closing a stake of 295 shares — an estimated $3K sold.

Geneos Wealth Management first reported a position in DVAX in Q1 2016 and held it in 25 quarters. The position peaked at $8K in Q3 2021. 236 funds tracked by Wall St. Rank hold DVAX as of Q3 2022.

Geneos Wealth Management reported no remaining Dynavax Technologies position as of Q3 2022 after selling out during the quarter.
Geneos Wealth Management sold 295 Dynavax Technologies shares in Q3 2022, an estimated $3K.
Geneos Wealth Management first reported a position in Dynavax Technologies in Q1 2016 and held it in 25 quarters.
Geneos Wealth Management's Dynavax Technologies position peaked at $8K in Q3 2021.
236 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.